The three most common critical illnesses include cancer, heart disease and stroke, which often have high recurrence rates1. Is your existing critical illness coverage sufficient? If you suddenly fall seriously ill with critical illness and need to recuperate, how will your family expenses be sustained?
Stop overthinking. Flip the script! Taking proactive steps can make all the difference. Manulife breaks through traditional critical illness benefit payout model, leading the new income concept for protection and providing you with an income annually from diagnosis to treatment2! The underwriting procedure is simple, allowing you to easily plan for the future!
IncomeShield Critical Illness Protector focuses on providing multiple claims for the diagnosis and treatment of cancer, heart attack (myocardial infarction) and stroke, available as often as annually as continuous income support. It also features simplified underwriting procedure - you only have to answer three health questions which mainly focus on your health conditions from the past two years.
The content of this website does not contain the full terms of the policy(ies), and the full terms can be found in the corresponding policy document(s).
Before making a purchase, you should read the policy provisions for the exact terms and conditions that apply to this product. You can ask us for a copy.
IncomeGuard Critical Illness Protector
provides coverages of up to 1,000% of the notional amount for the diagnosis and treatment of cancer, heart attack and stroke. Benefit payout can be available as often as annually, serving as a steady income support.
IncomeShield Critical Illness Protector is a critical illness insurance product provided and underwritten by Manulife (International) Limited (incorporated in Bermuda with limited liability). The above provides only general information on this product for your reference only. Please download the product leaflet now or ask your Insurance/Financial Advisor for a copy which will give you more details about this product including the ‘Important Information’ showing the product risks.